Citigroup’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.1M | Buy |
460,429
+96,202
| +26% | +$4.21M | 0.01% | 1008 |
|
|
2025
Q4 | $14.1M | Buy |
364,227
+110,773
| +44% | +$4.22M | 0.01% | 1310 |
|
|
2025
Q3 | $8.94M | Sell |
253,454
-132,843
| -34% | -$4.81M | 0.01% | 1570 |
|
|
2025
Q2 | $13.9M | Buy |
386,297
+52,407
| +16% | +$1.74M | 0.01% | 1176 |
|
|
2025
Q1 | $10.4M | Sell |
333,890
-23,145
| -6% | -$734K | 0.01% | 1341 |
|
|
2024
Q4 | $9.11M | Sell |
357,035
-171,467
| -32% | -$4.55M | 0.01% | 1446 |
|
|
2024
Q3 | $15M | Sell |
528,502
-66,237
| -11% | -$1.83M | 0.01% | 1111 |
|
|
2024
Q2 | $15.7M | Buy |
594,739
+122,896
| +26% | +$3.41M | 0.02% | 1010 |
|
|
2024
Q1 | $14.3M | Buy |
471,843
+143,850
| +44% | +$4.24M | 0.02% | 1052 |
|
|
2023
Q4 | $9.21M | Buy |
327,993
+48,840
| +17% | +$1.34M | 0.01% | 1263 |
|
|
2023
Q3 | $7.58M | Buy |
279,153
+32,580
| +13% | +$968K | 0.01% | 1237 |
|
|
2023
Q2 | $7.58M | Buy |
246,573
+74,629
| +43% | +$2.53M | 0.01% | 1262 |
|
|
2023
Q1 | $6.2M | Buy |
171,944
+69,140
| +67% | +$2.56M | 0.01% | 1378 |
|
|
2022
Q4 | $4.06M | Sell |
102,804
-20,479
| -17% | -$855K | 0.01% | 1571 |
|
|
2022
Q3 | $4.95M | Buy |
123,283
+8,893
| +8% | +$380K | 0.01% | 1572 |
|
|
2022
Q2 | $4.81M | Sell |
114,390
-39,557
| -26% | -$1.62M | 0.01% | 1561 |
|
|
2022
Q1 | $6M | Buy |
153,947
+37,054
| +32% | +$1.46M | 0.01% | 1573 |
|
|
2021
Q4 | $4.66M | Sell |
116,893
-13,665
| -10% | -$531K | ﹤0.01% | 1891 |
|
|
2021
Q3 | $4.72M | Buy |
130,558
+12,913
| +11% | +$502K | ﹤0.01% | 1862 |
|
|
2021
Q2 | $4.82M | Sell |
117,645
-47,690
| -29% | -$2.03M | ﹤0.01% | 1923 |
|
|
2021
Q1 | $7.21M | Buy |
165,335
+104,955
| +174% | +$4.98M | 0.01% | 1572 |
|
|
2020
Q4 | $3.02M | Buy |
60,380
+22,554
| +60% | +$957K | ﹤0.01% | 2474 |
|
|
2020
Q3 | $1.59M | Buy |
37,826
+37,626
| +18,813% | +$1.61M | ﹤0.01% | 2866 |
|
|
2020
Q2 | $10K | Buy |
+200
| New | +$9.9K | ﹤0.01% | 7060 |
|
Other funds holding RPRX
